What Are the Key Points of the Full Hong Kong IPO Process from Filing to Listing, and of the FINI Settlement Mechanism?
A Hong Kong IPO is a tightly regulated, market-driven process that typically takes 6 to 12 months. The key stages are as follows:
Stage 1: Application Filing and Regulatory Review (about 2–4 months)
Application submission (Form A1 stage): The sponsor submits Form A1 together with the preliminary prospectus to HKEX (Hong Kong Exchanges and Clearing Limited), which conducts a "completeness check". For mainland Chinese enterprises, an overseas-listing filing application must be submitted to the China Securities Regulatory Commission (CSRC) before or around this point — a mandatory precondition for all subsequent steps.
Regulatory inquiries: HKEX's Listing Division conducts multiple rounds of written inquiries covering business, financial and legal matters. The "Technology Enterprises Channel" offers pre-consultation and confidential filing support for specialist technology companies.
Listing Hearing: The Listing Committee convenes to deliberate. Upon approval, the company receives approval in principle and publishes the Post-Hearing Information Pack (PHIP) containing the offering details — the final document on which investors base their decisions.
Stage 2: Marketing and Pricing (about 1–2 weeks)
4. Roadshow and bookbuilding: Management conducts a global roadshow and communicates with institutional investors. Underwriters collect orders through bookbuilding, forming a demand curve from which the final offer price is determined.
Stage 3: Subscription, Allotment and Settlement (about 1 week)
5. Public subscription and placement: Retail investors subscribe through the public tranche while institutions participate through the international offering. Shares are allocated according to the clawback mechanism.
6. Final settlement and listing: All cash and share settlement is completed on the FINI platform. The stock begins trading officially on the first listing day.
Note: The total timeline is affected by corporate complexity, the number of inquiry rounds, market conditions, and whether the listing is an "A+H" listing.
Core Analysis of the New FINI Settlement Rules (T+2)
Since November 22, 2023, HKEX has operated its brand-new platform FINI, bringing the following key changes:
Cycle optimization: The IPO settlement cycle has been shortened dramatically from the old T+5 (listing 5 trading days after pricing) to T+2 (listing 2 trading days after pricing).
Main Significance and Impact:
Lower market risk: Greatly reduces the risk of market volatility between pricing and listing.
Higher capital efficiency: Significantly cuts the interest cost of investors' capital tied up — especially for those using margin financing to subscribe to new issues.
Innovated operating model: Through a unified digital platform, FINI coordinates issuers, underwriters, settlement participants and other parties, improving efficiency and transparency while enabling better monitoring of duplicate subscriptions.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- NewTimeSpace|IPO Decoding: Shanghai W-Ibeda High Tech Group Files for HKEX Listing, NEV Testing Leader Pursues Global Layout
- NewTimeSpace | IPO Decoding: Zeroth AI: The Dark Horse of China’s Enterprise AI Agent Race Sprints for HKEX
- NewTimeSpace|IPO Decoding: ICS Group Files for HKEX Listing, Aims to Be First China Enterprise Going‑Global Service Stock, with Full Licenses Building Moat
- "The First Stock for Hair Loss Treatment" Mandi Inc. (MD) Receives Supplementary Material Request for Overseas Listing Filing, Required to Explain Discrepancies in Controlling Shareholder Identification